Whole‐Body Oxygen‐Enhanced MRI of Tumor‐Bearing Mice Under Hyperbaric Oxygenation
Magnetic Resonance in Medicine · 2026-10 · 96 (4) · 1860-1871
DOI: 10.1002/mrm.70458 ↗At a glance
Journal article in Magnetic Resonance in Medicine, published online on 2026-06-11. Written by Conner S Ubert and 7 co-authors. Institution: Department of Radiology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA. Major MEDLINE topics: Hyperbaric Oxygenation, Oxygen, Magnetic Resonance Imaging, Whole Body Imaging. 41 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIH HHS, NIBIB NIH HHS.
Abstract (original language)
Purpose
Oxygen‐enhanced MRI (OE‐MRI) enables noninvasive assessment of tissue oxygenation by exploiting the paramagnetic effect of molecular oxygen on longitudinal relaxation. The purpose of this study was to evaluate whether whole‐body oxygen‐enhanced MRI (OE‐MRI) can be performed under hyperbaric oxygen (HBO) conditions and to assess its utility for detecting oxygenation changes in a small‐animal tumor model using a clinical 3 T scanner.
Methods
A fully MRI‐compatible HBO chamber was built for imaging mice and installed in a 3 T clinical scanner. SCC7‐tumor‐bearing C3H mice underwent whole‐body OE‐MRI with variable flip‐angle T 1 mapping. Longitudinal relaxation‐rates ( R 1 ) and Δ R 1 were measured while the animals breathed 21% O 2 at 1 ATA, 21% O 2 at 2 ATA, 100% O 2 at 1 ATA, and 100% O 2 at 2 ATA. Δ R 1 was quantified in tumor, brain, and heart regions.
Results
High‐quality OE‐MRI was obtained under all hyperbaric conditions. Normal tissues (brain, heart) showed uniform, pressure‐dependent increases in Δ R 1 with higher inspired oxygen fractions. Tumors displayed pronounced spatial heterogeneity: many voxels responded robustly, while others showed little or no Δ R 1 change even at 2 ATA 100% O 2 . The proportion of oxygen‐responsive tumor voxels rose with increasing pressure, yet non‐responsive regions persisted.
Conclusion
Whole‐body pre‐clinical OE‐MRI on a clinical 3 T system is feasible and sensitive under hyperbaric oxygenation, capturing both tissue‐level pressure effects and heterogeneous tumor oxygen responses. This non‐invasive HBO‐OE‐MRI platform provides a valuable pre‐clinical tool for assessing oxygen delivery and identifying oxygen‐refractory tumor zones, supporting oxygen‐guided therapeutic strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Radiology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.
- Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA.
- Department of Radiation Oncology and Applied Sciences, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.
- Department of Surgery, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.
ORCID profiles: Conner S Ubert, Periannan Kuppusamy
Funding
- NCI NIH HHS
- NIH HHS
- NIBIB NIH HHS
- National Cancer Institute
- National Institutes of Health
Cite
APA
Ubert, C. S., Kmiec, M. M., Lara Mejia, P. S., Kheirollah, A., O'Connell, R. C., Petryakov, S. V., Schaner, P. E., & Kuppusamy, P. (2026). Whole‐Body Oxygen‐Enhanced MRI of Tumor‐Bearing Mice Under Hyperbaric Oxygenation. Magnetic Resonance in Medicine, 96(4), 1860-1871. https://doi.org/10.1002/mrm.70458
Vancouver
Ubert CS, Kmiec MM, Lara Mejia PS, Kheirollah A, O'Connell RC, Petryakov SV, et al. Whole‐Body Oxygen‐Enhanced MRI of Tumor‐Bearing Mice Under Hyperbaric Oxygenation. Magnetic Resonance in Medicine. 2026;96(4):1860-1871. doi:10.1002/mrm.70458
BibTeX
@article{Ubert2026,
author = {Ubert, Conner S and Kmiec, Maciej M and Lara Mejia, Paula S and Kheirollah, Alireza and O'Connell, Ryan C and Petryakov, Sergey V and Schaner, Philip E and Kuppusamy, Periannan},
title = {Whole‐Body Oxygen‐Enhanced MRI of Tumor‐Bearing Mice Under Hyperbaric Oxygenation},
journal = {Magnetic Resonance in Medicine},
year = {2026},
volume = {96},
number = {4},
pages = {1860--1871},
doi = {10.1002/mrm.70458}
}
EUVIMED